Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors

被引：0

作者：

Kang, Tongtong ^{[1
]}

Sun, Simin ^{[1
]}

Wang, Huimin ^{[1
]}

Liu, Jinyu ^{[1
]}

Li, Xiaoyang ^{[1
,2
,3
]}

Jiang, Yuqi ^{[1
,2
,3
]}

机构：

[1] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, 5 Yushan Rd, Qingdao 266003, Peoples R China

[2] Ocean Univ China, Ctr Targeted Prot Degradat & Drug Discovery, Qingdao 266003, Shandong, Peoples R China

[3] Marine Biomed Res Inst Qingdao, Qingdao 266071, Shandong, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 113卷

基金：

中国国家自然科学基金;

关键词：

NLRP3; inhibitors; Diphenylamine; inflammasome; Anti-inflammatory; Pyroptosis; POTENTIAL TREATMENT;

D O I：

10.1016/j.bmc.2024.117927

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The aberrant activation of the NLRP3 inflammasome has been implicated in the pathogenesis of numerous inflammation-related diseases. Development of NLRP3 inflammasome inhibitors is expected to provide a new strategy for the treatment of these diseases. Herein, a novel series of diphenylamine derivatives were designed based on the lead compounds H20 and H28, and the preliminary structure-activity relationship was studied. The representative compound 19 displayed significantly higher inhibitory activity against NLRP3 inflammasome compared to lead compounds H20 and H28, with an IC50 of 0.34 mu M. Mechanistic studies indicated that compound 19 directly targets the NLRP3 protein (K-D: 0.45 mu M), blocking the assembly and activation of the NLRP3 inflammasome, leading to anti-inflammatory effects and inhibition of cellular pyroptosis. Our findings indicated that compound 19 is a promising NLRP3 inhibitor and could potentially serve as a lead compound for further optimization.

引用

页数：16

共 45 条

[1] Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer [J].

Albanese, Valentina ;

Missiroli, Sonia ;

Perrone, Mariasole ;

Fabbri, Martina ;

Boncompagni, Caterina ;

Pacifico, Salvatore ;

De Ventura, Tiziano ;

Ciancetta, Antonella ;

Dondio, Giulio ;

Kricek, Franz ;

Pinton, Paolo ;

Guerrini, Remo ;

Preti, Delia ;

Giorgi, Carlotta .

JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) :5223-5241

[2] Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis [J].

Chen, Liu Zeng ;

Zhang, Xing Xing ;

Liu, Ming Ming ;

Wu, Jing ;

Ma, Duo ;

Diao, Liang Zhuo ;

Li, Qingshan ;

Huang, Yan Shuang ;

Zhang, Rui ;

Ruan, Ban Feng ;

Liu, Xin Hua .

JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (18) :13633-13657

[3] A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases [J].

Coll, Rebecca C. ;

Robertson, Avril A. B. ;

Chae, Jae Jin ;

Higgins, Sarah C. ;

Munoz-Planillo, Raul ;

Inserra, Marco C. ;

Vetter, Irina ;

Dungan, Lara S. ;

Monks, Brian G. ;

Stutz, Andrea ;

Croker, Daniel E. ;

Butler, Mark S. ;

Haneklaus, Moritz ;

Sutton, Caroline E. ;

Nunez, Gabriel ;

Latz, Eicke ;

Kastner, Daniel L. ;

Mills, Kingston H. G. ;

Masters, Seth L. ;

Schroder, Kate ;

Cooper, Matthew A. ;

O'Neill, Luke A. J. .

NATURE MEDICINE, 2015, 21 (03) :248-+

[4] Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis [J].

Dai, Zhen ;

Chen, Xiao-Yi ;

An, Lu-Yan ;

Li, Cui-Cui ;

Zhao, Ni ;

Yang, Fan ;

You, Song-Tao ;

Hou, Chen-Zhi ;

Li, Kan ;

Jiang, Cheng ;

You, Qi-dong ;

Di, Bin ;

Xu, Li-Li .

JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (01) :871-889

[5]

Fang K, 2024, Pharm Sci Adv, V2

[6] Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization [J].

Fulp, Jacob ;

He, Liu ;

Toldo, Stefano ;

Jiang, Yuqi ;

Boice, Ashley ;

Guo, Chunqing ;

Li, Xia ;

Rolfe, Andrew ;

Sun, Dong ;

Abbate, Antonio ;

Wang, Xiang-Yang ;

Zhang, Shijun .

JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) :5412-5423

[7] Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 lnflammasome Inhibitor for Potential Treatment of Multiple Sclerosis [J].

Guo, Chunqing ;

Fulp, Jacob W. ;

Jiang, Yuqi ;

Li, Xia ;

Chojnacki, Jeremy E. ;

Wu, Jingde ;

Wang, Xiang-Yang ;

Zhang, Shijun .

ACS CHEMICAL NEUROSCIENCE, 2017, 8 (10) :2194-2201

[8] Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders [J].

Harrison, David ;

Billinton, Andy ;

Bock, Mark G. ;

Doedens, John R. ;

Gabel, Christopher A. ;

Holloway, M. Katharine ;

Porter, Roderick A. ;

Reader, Valerie ;

Scanlon, Jane ;

Schooley, Kenneth ;

Watt, Alan P. .

JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (21) :14897-14911

[9] Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity [J].

He, Hongbin ;

Jiang, Hua ;

Chen, Yun ;

Ye, Jin ;

Wang, Aoli ;

Wang, Chao ;

Liu, Qingsong ;

Liang, Gaolin ;

Deng, Xianming ;

Jiang, Wei ;

Zhou, Rongbin .

NATURE COMMUNICATIONS, 2018, 9

[10] Discovery of novel biphenyl-sulfonamide analogues as NLRP3 inflammasome inhibitors [J].

Huang, Chao ;

Liu, Jinyu ;

Chen, Yuxin ;

Sun, Simin ;

Kang, Tongtong ;

Jiang, Yuqi ;

Li, Xiaoyang .

BIOORGANIC CHEMISTRY, 2024, 146

← 1 2 3 4 5 →